Loading chat...

NJ S518

Bill

Official Source

Status

Introduced

1/9/2024

Primary Sponsor

James Holzapfel

Click for details

Origin

Senate

2024-2025 Regular Session

AI Summary

  • Allows patients to voluntarily add an indication to their prescription monitoring program profile stating they should not be prescribed opioid drugs or controlled substances with significant abuse or addiction potential
  • Requires the Division of Consumer Affairs to establish processes for patients to both add and remove this no-prescription indication from their records at their request
  • Mandates creation of a method for patients to communicate their no-opioid preference when incapacitated or unable to speak during medical care
  • Requires the division to develop an education and outreach program for health care providers about this voluntary patient preference system
  • Amends New Jersey's existing prescription monitoring program law (P.L.2007, c.244) and takes effect immediately upon enactment

Legislative Description

Requires Division of Consumer Affairs display list of all registered ticket brokers on division's website.

Commerce

Last Action

Introduced in the Senate, Referred to Senate Commerce Committee

1/9/2024

Committee Referrals

Commerce1/9/2024

Full Bill Text

No bill text available